Patent Assignment
Reel/Frame 053821/0205
Change of Name
Recorded: 2020-09-18
Pages: 2
Assignor
UCB BIOPHARMA SPRL
Executed: 2019-12-02
Assignee
UCB BIOPHARMA SRL
ALLÉE DE LA RECHERCHE 60, BRUSSELS, 1070, BELGIUM
Covered Property
(1)
Antagonist Antibodies That Bind to Human TGFB1, TGFB2 and to TGFB3 and Their Use for the Treatment of Lung Fibrosis
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.